Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, September 17, 2020. [File, Reuters]
US regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.